Professional Documents
Culture Documents
3 - Other Therapeutic Modalities
3 - Other Therapeutic Modalities
A. IMMUNOTHERAPY
● Using biologic response therapy or also known as
“Biological response modifier therapy or biotherapy”
○ It is used to modify the biologic processes
that result in malignant cells, primarily
through enhancing the person’s own
immune responses.
○ Intended for the treatment of various
cancers like bladder cancer, brain cancer
or tumor, breast cancer, cervical ovarian
cancer, colorectal cancer or colon cancer,
kidney liver lung cancer and even
leukemia
○ Depending on the agents biological
response can be given in routes: Oral and
IV
Additional Notes:
● Immunotherapy can be given alone or in
combination with other types of cancer
treatment like immunotherapy with
chemotherapy or immunotherapy with
radiation therapy.
B. PHOTODYNAMIC THERAPY
● Phototherapy/photoradiation/photochemotherapy
○ This is a new method of treating certain
kinds of superficial tumors.
○ Two stage treatment that combines a life
energy with a drug called ‘photosensitizer’
designed to destroy cancerous and
precancerous cells after a live activation.
Photosensitizer is activated by a specific
wavelength of light energy usually from a
laser
● Photofin
○ an intravenous dose of photosensitizing
compound, which is selectively retained in
D. HORMONE THERAPY
higher concentrations of malignant tissue
● Because steroid hormones are powerful drivers of
and
gene expression in certain cancer cells, changing
○ a laser light therapy to reduce the size of
the levels of activity of certain hormones can cause
tumors in the lungs or esophagus
1
certain cancers to cease growing, or even undergo CELLULAR ABERRATION IN DIFFERENT SITES
cell death.
○ used as an adjunct to other types of CA BREAST CANCER
therapy
○ it can slow tumor growth or prevent
re-occurence
○ a treatment that is used together with a
primary treatment: chemo with hormone
therapy, to assist or support the primary
treatment
○ a medication that contains female
hormones, replaces estrogen that the body
stops making during menopause
PAIN IN CANCER
CAUSES
1. Bone marrow destruction
2. Obstruction of an organ
3. Compression of peripheral nerves
4. Infiltration or distention of tissue
5. Inflammation, infection and necrosis TYPES OF BREAST CANCER
A. Carcinoma in Situ
Psychological Causes ● Characterized by the proliferation of
● Depends on the client’s perceived threat malignant cells within the ducts and
1. Fear of anxiety generated from the effects lobules, without invasion into the
2. Loss or threat of loss surrounding tissue
3. frustration
Two Types:
ASSESSMENT 1. Ductal Carcinoma in Situ (DCIS)
1. Severity and duration 2. Lobular Carcinoma in Situ (LCIS)
2. What, when and where pain occurs
3. Understand as client views it B. Invasive Carcinoma
4. Nature of the disease ● Arises from the intermediate ducts of the
5. Probable life expectancy breast and may involve surrounding breast
6. Temperament and psychological state tissue, lymph, and blood vessels
7. Occupational, economic, educational background
8. Vital signs Seven Types:
a. Low to moderate pain and superficial in 1. Infiltrating Ductal Carcinoma
origin (sympathetic) ● most common type 75-80%
● Increase BP, PR, RR, and muscle ● arise from duct and invade
tension ● often form a solid mass in breast;
b. Severe pain or visceral in origin usually hard in palpation;
(parasympathetic) prognosis is poor
● Decrease BP, PR, N/V, weakness
9. Behavior as indicator of pain 2. Infiltrating Lobular Carcinoma
a. Posture ● arise from the lobules; 5-10 %
b. Gesture ● occur as an area of ill-defined
c. Daily activities thickening in the breast, spread in
bone, lungs, liver and brain
MEDICATION MANAGEMENT
1. Acetaminophen, ASA, NSAID (mild pain) 3. Medullary Carcinoma
2. Opioids - CODEINE ● accounts 15%; other books 6%
a. Added regimen as pain increases cases
1. Intraspinal Morphine Administration ● tumor grow in capsule; mistaken
a. An implantable infusion pump delivers a as fibroadenoma because the
continual supply of opiate to the epidural or mass is large; tumor is soft (flesh
subarachnoid space mass)
● prognosis: favorable (doesn’t
SURGICAL MANAGEMENT grow quickly and spread)
1. Nerve block
a. Involves interruption of nerve pathways 4. Mucinous Cancer
some place along the path of transmission ● mucin produce cancer; produces
from periphery to brain. mucus
2. Non invasive Modalities ● slow growing mass
● Transcutaneous Nerve Stimulation (TENS) ● Prognosis: favorable (rarely
○ Electrical stimulation of the skin spreads to the lymph nodes)
surface over a painful area
5. Tubular Ductal Carcinoma
2
● 2% of cases ● Change in size and shape of breat
● Prognosis: excellent (axillary ● Dimpling, pulling, or retractions
metastasis is uncommon) ● Peau d’ orange skin
● mass is small: 1 cm or less ● Persistent skin rash near nipple
● Faking or eruption near the nipple; dry, scaling,
6. Inflammatory Carcinoma ddark coloring, redness.
● rare type of breast CA
● 1-2 % (aggressive form of B Ca) DIAGNOSTIC EXAMS
● Characterize of diffuse edema ● Breast self-exam
and brawny erythema (skin of the ● Clinical breast self-exam
breast become briskly/ red)-due ● Baseline mammogram between age 40 & 49;
to malignant cells that will block annual mammogram after age 50
the lymph channels in the skin
● referred as “peau d’ orange” - Imaging Studies
orange like skin ● Ultrasonography
● mass is tender and painful when ● CT scan
palpated ● MRI
● can cause nipple retraction ● PET scan
3
● Quadrantectomy
tissue
2. Axillary lymph node dissection
IIIb More MRM Post-op & To chest ● A surgery to remove the lymph
advanced possibly wall and nodes from the armpit or
lesions pre-op possibly underarm or axilla
with axillae
satellite after 3. Total Mastectomy
nodules, MRM ● Removes the entire breast
fixation to
the skin 4. Modified Radical Mastectomy
or chest
wall, 5. Radical mastectomy
ulceration ● A surgical procedure involving the
, edema removal of the breast underlying
chest muscle (pectoralis
IV All tumors Possibly To control To control major/minor)
with lumpecto progressi progressi
distant my or on and/or on and/or 6. Breast Reconstruction
mets mRM palliation palliation
Scoring:
3,4, or 5 = Grade 1 tumor
6 or 7 = Grade 2 tumor (moderately differentiated)
8 or 9 = Grade 3 tumor (poorly differentiated)
1 - closest to normal
3 - abnormal
● Tissue Expanders
● These 3 scores are added together making the ○ An empty breast implant
Nottingham System placed during
mastectomy
Maximum score - 9 ○ Done at outpatient
department
1= closest to normal ○ Once tissue expander is
3= normal in place, the surgeon will
put on liquid in 6-12
TREATMENT weeks
A. Medical Management ○ Stretch tissue around it
1. Chemotherapy : combination therapy to make stitch around
● Doxorubicin (Adriamycin) breast implant
● Methotrexate ● Transverse Rectus Abdominis
● 5-fluorouracil Muscle Flap
○ Kukuha sa ibang parte
2. Hormonal therapy: ○ Forms a natural looking
● Androgens: fluorymesterone breast
(Halotestin) ○ Does not need a breast
● Estrogens: diethylstilbestrol implant
(DES) ○ Skin grafting
● Antohormonal agents: Tamoxife ● Latissimus Dorsi Muscle Free flap
○ An oval flap of the skin
3. Radiation therapy (fat muscle, blood
● Typically begins about 6 weeks vessel,l from the upper
after the surgery to allow the back is used to
incision to heal reconstruct the breast)
● Nipple-Areola Reconstruction
B. Surgical Management ○ Done outpatient
1. Breast-conserving procedures procedure that uses the
● Lumpectomy skin from the area of the
● Wide excision breast where the nipple
● Partial mastectomy are located
● Segmental mastectomy
4
○ Uses skin from the area 3. Prevent infection and injury
of the breast where ● Encourage compliance of antibiotics
nipple is located to form ● Make sure the pt and family understands
a new nipple ● Observe proper aseptic technique
● Make sure all materials are sterile
NURSING MANAGEMENT ● Monitor VS (high temp, high HR) and LOC
Diagnostic Phase: (level of consciousness)
1. Minimize uncertainty ● Prevent falls since pt is drowsy from
2. Prevent disease advancement anesthesia
3. Protect emotional well-being 4. Promote positive adjustment and coping
● Difficult phase where the family is having a ● Teach coping strategies and lifestyle
difficulty of accepting the disease changes
4. Establish trusting communication ● 5. Monitor drainage, monitor bleeding
● Monitor for oozing in post-op dressing
Adjuvant Therapy Phase
1. Develop a supportive network PROSTATE CANCER
2. Minimize adverse physical outcomes ● form of cancer that begins in the gland cells of the
3. Manage stress prostate
● Cancer is one of the most stressful ● 2nd leading cause of death in males
moments in life with added stress from ● Most men with early prostate cancer do not notice
family, work and financial problems. any signs and symptoms - 80% of cases identified
● Understand family members’ responses after age 80
● Can take upto 30 years to be identified
Ongoing Recovery Phase ● Fertility is not a factor
1. Maintain association with professionals
● Collaborative care RISK FACTORS
○ Ex. Dietary - talk to dieticians, 1. Increasing age (after 50 years old)
NGT 2. African-americans (twice more likely than
○ Ex. PT - consult Caucasians)
2. Maintain positive outlook 3. High fat diet (lowest incidence in Japanese)
● Act with positive thinking ● 2 per 100,000 in Japan
● Positive thinking = lowers stress, improves ● 14 per 100,000 in US
overall wellbeing 4. Genetics - 8x more risk if 1st and 2nd degree
3. Redefine self and partner relative
● It is normal for CA patients to feel anxious, ● Also having family history of breast and
nervous, angry, or depressed ovarian CA (BRCA gene mutations)
● CA drugs can cause trouble concentrating 5. Relatives are affected
and remembering
4. Cultivate ongoing support SIGNS AND SYMPTOMS
● Cancer support groups have many ● Asymptomatic in early stages
benefits ● Urinary symptoms: frequency, dribbling
(mahirapan mag ihi), retention, obstruction,
Preoperative Nursing Intervention hematuria, cystitis (related to UTI)
1. Explain breast CA, correct misconceptions, and
treatment options ● Bone metastases results in hip pain, back ached,
● Misconceptions - CA is contagious weight loss, perineal (perineal pain) and rectal
● Tx options - expectations (Nausea and discomfort
vomiting 6h after chemo)
2. Reduce fear DIAGNOSIS
● Talk and explain according to the patient’s ● DRE (digital rectal examination)
level of understanding - rectal exam using index finger
3. Reduce anxiety ● Biopsy
● Normal to be anxious - Core needle biopsy – the main method
● Explain procedure to patient used to diagnose prostate cancer; usually
4. Improving coping ability done by a urologist; guided with ultrasound
● Include family support
5. Promote decision making ability ● T-R USD (Trans-Rectal Ultrasound)
● Give time to think if for surgery or for ● PSA (prostate specific antigen) – may be (+) in BPH
chemo and prostatitis
- (swelling/inflammation of prostate gland) –
Postoperative Nursing Intervention routine screening; important to detect
1. Relieve pain and discomfort prostate cancer at an early stage
● Administration of pain relievers as ● ACID PHOSPHATASE – increased in 2/3 of patient;
medicated
● Score patient’s pain more predictive of metastasis
2. Maintain skin integrity - Aka prostatic acid phosphatase –
● Check and change post-operative dressing produced in the prostate; first major zero
as needed marker for prostate cancer
● Change pt’s position (turning to sides q2h)
5
● ALKALINE PHOSPHATASE + Bone Scan =
metastasis
- Metastasis in the bone which causes a rise
in acid phosphatase level; with the level
increasing in correspondence to the extent
of the disease
- When it spreads beyond the prostate, it
usually moves to the bones; kaya common
spread ng prostate cancer kay sa pelvis
and spine (common area of prostate RISK FACTORS
cancer metastasis) 1. Early menarche
2. Late menopause
MANAGEMENT 3. Overweight
● Pomegranate juice 4. Never had kids
● Radiation: Brachytherapy 5. Missed periods
● Orchiectomy/cryoablation 6. Bladder infections
● Surgery: Radical Prostatectomy 7. Spotting or abnormal vaginal bleeding (twice a
● Teletherapy month, etc.)
● Analgesics 8. Cumulative exposure to estrogen
● The use of chemotherapy 9. Familial tendency
● E-hormal therapy YAN 10. DM, HPN, gallbladder disease
11. Ovarian neoplasm decrease sex hormone
12. Tamoxifen
DIAGNOSTIC TEST
- Annual PE / Gyne Exam
- Biopsy
- Papsmear - 50% of patients with abnormal results
- Schiller's test (Lugol's Test) - Cervical tisuue
staining; CA cells resist the stain.
- MRI or CT scan - Evaluates myometrial invasion
HORMONE THERAPY and LN involvement
● Luteinizing hormone-releasing hormone agonists - CA 125
(LHRH agonists.)
● Anti-androgens MANAGEMENT
UTERUS
NURSING PROBLEMS U-se of chemotherapy
● Altered urinary elimination T-ake hormonal agents
● Pain E-mphasize follow-up care
● Sexual dysfunction / Body Image disturbance R-adiation: External/Intracavity
● Urinary retention U-tmost psychosocial support
● Altered role performance S-urgery: TAH/TAHBSO
● Use gloves
● Hydrate and monitor I & O (good nutrition helps
flush toxins in the body and reduce treatment for the
side effects)
● Do not use ordinary rubber catheter during
Chemotherapy- Use TEFLON
LIVER CANCER
● A rare form of cancer with a high mortality rate
6
● 90% arise from the liver parenchymal cells
(hepatoma) ● Oncogenic foods - diet low in fruits and vegetables
● Some originate from the intrahepatic bile duct (mahilig sa meat sucha as beef &pork, processed
(cholangioma) foods
● L-iver toxins( vinyl chloride,
Additional notes: arsenic)
- Hepato cellular carcinoma and cholangioma or Additional notes:
cholangio carcinoma- most common type of liver - exposure can contribute to increase risk of liver
cancer cancer.
- Hepato cellular carcinoma -begins in main type of - Vinyl chloride - commonly used chemical in
deliver cell (hepatocyte) commercial industry
- Intra hepatic cholangio carcinoma - ingredient in making a certain plastic
- Arsenic- also in industrial company
7
● hepatojugular reflux sign Additional notes:
● Serum albumin (3.4-5.4 g/dl) - The brain metastases occurs when the cancer cell
● AFP (alpha-feto protein) spread from their original site
● Liver scan, USD, CT, MRI, PET scan - Any cancer can spread to the brain but the common
● needle biopsy type is caused by brain metastases
● increased serum ammonia - Brain metastases may form one tumor or many
● serum crea, BUN tumors in the brain
CHEMOTHERAPY
→ adjuvant prior to surgery
RADIATION THERAPY
→ for unresectable tumors, palliative so NO significant
change in survival rate.
Additional Notes:
- the objective is to preoperatively reduce tumor size
TRANSCATHETER CHEMOEMBOLIZATION
→ the chemotherapeutic agent is injected to the hepatic
artery
→ effective in shrinking tumors
BRAIN TUMOR
● Localized intracranial lesion that occupies space
within the skull
● Primary- originates from cells and structures within
the brain
● Secondary- tumors that develop from the outside of
the brain
GROUPS OF TUMOR
➔ Arising from the coverings of the brain
(meningioma)
➔ Arising from the cranial nerves ( acoustic neuroma/
vestibular schwannoma)
➔ Originating from brain tissue (gliomas)
➔ Metastatic
INCIDENCE
- The cause is unknown
- Metastatic CA is the most CA in the brain
- 25% of people with CA develop brain metz
(metastases)
8
d. Weakness / numbness / paralysis in one
side of the body
e. Loss of balance
f. Dizziness
g. Unsteadiness
h. Loss of hearing
i. Vision changes
INCREASED ICP
1. Classic Signs: DIAGNOSIS
● Headache - aggravated by straining (carrying heavy ✔ CT scan
stuff, having constipation) Additional notes:
● Vomiting - irritation of vagal centers in medulla o Proper preparation is needed
● Papilledema - present in 70% of patients (serious o Check jewelries
medical condition, the optic nerve becomes swollen, ✔ MRI
can cause vision problems) Additional notes:
o Proper preparation is needed
Additional notes:
- It occurs when there is swelling and the brain is o Check jewelries
pushing against the skull ✔ Cerebral angiography
Additional notes:
CUSHING’S TRIAD o This test will use a catheter, x-ray imaging
Additional notes: guidance, and injection of a contrast
- Recognize that the body’s initial response to rising material to examine the blood vessels in
ICP arise in systolic blood pressure the brain for abnormalities
- The rising of the systolic pressure results in o This can also be used in heart
widening pulse pressure (bradycardia) and irregular ✔ EEG
breathing Additional notes:
1. Increased BP – hypertension o Electroencephalography
2. Slow pulse – bradycardia // below normal o This should be prepared a day before the
3. Altered breathing – apnea test
o It detects the abnormalities in the brain
waves or in the electoral activity of the
brain
o There are electrodes consisting of small
metal disk with thin wires placed on the
scalp of the patient
o This is to detect tiny electrical charges that
result from the activity of the brain cells
✔ CSF studies (cytology)
Additional notes:
o Cerebrospinal fluid studies
o CSF will be taken from the spinal column
and sent to lab
Personality changes - behavioral changes of the patient o Doctor will be the one to extract not the
Focal deficits in motor, sensory, and cranial nerve function nurse
a. seizure or convulsion - 1st symptom: 8 out
of 10
b. Headache
c. Difficulty of thinking
9
MANAGEMENT
1. Craniotomy - remove tumor whenever possible
2. Radiation & Chemotherapy - may follow surgery;
also for inaccessible & metastatic tumors
3. Watch for wound breakdown & ICP
4. Drug treatment - hyperosmotic agents, steroids, &
diuretics to manage increased ICP
NURSING MANAGEMENT
● VS/NVS monitoring -
● Watch for increased ICP
● Administer meds as ordered
● Supportive care for neuro deficits
● Pre-op care/Chemo care
● Psychologic support
● Document seizure activity
● Watch for pupillary dilation & loss of light reflex
REFERENCES
10